Logo image of AAL

AMERICAN AIRLINES GROUP INC (AAL) Stock Fundamental Analysis

NASDAQ:AAL - Nasdaq - US02376R1023 - Common Stock - Currency: USD

15.23  -0.63 (-3.97%)

After market: 15.24 +0.01 (+0.07%)

Fundamental Rating

3

Overall AAL gets a fundamental rating of 3 out of 10. We evaluated AAL against 23 industry peers in the Passenger Airlines industry. AAL may be in some trouble as it scores bad on both profitability and health. AAL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AAL had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: AAL reported negative net income in multiple years.
In multiple years AAL reported negative operating cash flow during the last 5 years.
AAL Yearly Net Income VS EBIT VS OCF VS FCFAAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

AAL's Return On Assets of 1.37% is in line compared to the rest of the industry. AAL outperforms 56.52% of its industry peers.
AAL's Return On Invested Capital of 6.25% is fine compared to the rest of the industry. AAL outperforms 65.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AAL is below the industry average of 8.77%.
The 3 year average ROIC (5.50%) for AAL is below the current ROIC(6.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.37%
ROE N/A
ROIC 6.25%
ROA(3y)0.96%
ROA(5y)-2.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.5%
ROIC(5y)N/A
AAL Yearly ROA, ROE, ROICAAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

AAL's Profit Margin of 1.56% is in line compared to the rest of the industry. AAL outperforms 56.52% of its industry peers.
In the last couple of years the Profit Margin of AAL has declined.
AAL's Operating Margin of 5.95% is in line compared to the rest of the industry. AAL outperforms 56.52% of its industry peers.
AAL's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 63.55%, AAL is doing good in the industry, outperforming 73.91% of the companies in the same industry.
AAL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.95%
PM (TTM) 1.56%
GM 63.55%
OM growth 3YN/A
OM growth 5Y-5.99%
PM growth 3YN/A
PM growth 5Y-15.78%
GM growth 3Y3.64%
GM growth 5Y0.67%
AAL Yearly Profit, Operating, Gross MarginsAAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AAL is destroying value.
Compared to 1 year ago, AAL has more shares outstanding
The number of shares outstanding for AAL has been increased compared to 5 years ago.
Compared to 1 year ago, AAL has an improved debt to assets ratio.
AAL Yearly Shares OutstandingAAL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AAL Yearly Total Debt VS Total AssetsAAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

AAL has an Altman-Z score of 0.78. This is a bad value and indicates that AAL is not financially healthy and even has some risk of bankruptcy.
AAL has a Altman-Z score of 0.78. This is comparable to the rest of the industry: AAL outperforms 52.17% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.78
ROIC/WACC0.89
WACC7.02%
AAL Yearly LT Debt VS Equity VS FCFAAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

AAL has a Current Ratio of 0.55. This is a bad value and indicates that AAL is not financially healthy enough and could expect problems in meeting its short term obligations.
AAL has a worse Current ratio (0.55) than 60.87% of its industry peers.
AAL has a Quick Ratio of 0.55. This is a bad value and indicates that AAL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.44, AAL is doing worse than 69.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.44
AAL Yearly Current Assets VS Current LiabilitesAAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

4

3. Growth

3.1 Past

AAL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.65%.
AAL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.21% yearly.
Looking at the last year, AAL shows a small growth in Revenue. The Revenue has grown by 2.70% in the last year.
The Revenue has been growing slightly by 3.44% on average over the past years.
EPS 1Y (TTM)-27.65%
EPS 3YN/A
EPS 5Y-17.21%
EPS Q2Q%196.55%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y21.96%
Revenue growth 5Y3.44%
Sales Q2Q%4.58%

3.2 Future

The Earnings Per Share is expected to grow by 19.51% on average over the next years. This is quite good.
AAL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.74% yearly.
EPS Next Y27.01%
EPS Next 2Y28.34%
EPS Next 3Y25.68%
EPS Next 5Y19.51%
Revenue Next Year6.47%
Revenue Next 2Y5.63%
Revenue Next 3Y5.16%
Revenue Next 5Y3.74%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AAL Yearly Revenue VS EstimatesAAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
AAL Yearly EPS VS EstimatesAAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 -5 -10 -15 -20

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.97, the valuation of AAL can be described as very cheap.
Based on the Price/Earnings ratio, AAL is valued cheaper than 91.30% of the companies in the same industry.
AAL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
Based on the Price/Forward Earnings ratio of 6.28, the valuation of AAL can be described as very cheap.
Based on the Price/Forward Earnings ratio, AAL is valued cheaply inside the industry as 91.30% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, AAL is valued rather cheaply.
Industry RankSector Rank
PE 7.97
Fwd PE 6.28
AAL Price Earnings VS Forward Price EarningsAAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAL Per share dataAAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

AAL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AAL's earnings are expected to grow with 25.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y28.34%
EPS Next 3Y25.68%

0

5. Dividend

5.1 Amount

No dividends for AAL!.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN AIRLINES GROUP INC

NASDAQ:AAL (2/21/2025, 8:00:00 PM)

After market: 15.24 +0.01 (+0.07%)

15.23

-0.63 (-3.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)01-23 2025-01-23/bmo
Earnings (Next)04-23 2025-04-23/bmo
Inst Owners62.65%
Inst Owner Change16.26%
Ins Owners1.22%
Ins Owner Change-2.93%
Market Cap10.01B
Analysts75.56
Price Target21.02 (38.02%)
Short Float %7.95%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.38%
Min EPS beat(2)33.2%
Max EPS beat(2)89.57%
EPS beat(4)3
Avg EPS beat(4)27.48%
Min EPS beat(4)-15.81%
Max EPS beat(4)89.57%
EPS beat(8)6
Avg EPS beat(8)43.57%
EPS beat(12)9
Avg EPS beat(12)31.23%
EPS beat(16)13
Avg EPS beat(16)25.03%
Revenue beat(2)2
Avg Revenue beat(2)0.57%
Min Revenue beat(2)0.17%
Max Revenue beat(2)0.97%
Revenue beat(4)2
Avg Revenue beat(4)-0.32%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)0.97%
Revenue beat(8)3
Avg Revenue beat(8)-0.37%
Revenue beat(12)3
Avg Revenue beat(12)-0.48%
Revenue beat(16)4
Avg Revenue beat(16)-0.49%
PT rev (1m)16.48%
PT rev (3m)73.73%
EPS NQ rev (1m)-2108.89%
EPS NQ rev (3m)-526.02%
EPS NY rev (1m)8.1%
EPS NY rev (3m)18.74%
Revenue NQ rev (1m)0.78%
Revenue NQ rev (3m)-0.44%
Revenue NY rev (1m)1.94%
Revenue NY rev (3m)1.94%
Valuation
Industry RankSector Rank
PE 7.97
Fwd PE 6.28
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.91
EY12.54%
EPS(NY)2.43
Fwd EY15.93%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS82.44
BVpS-6.05
TBVpS-15.38
PEG (NY)0.3
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.37%
ROE N/A
ROCE 8.53%
ROIC 6.25%
ROICexc 7.67%
ROICexgc 9.58%
OM 5.95%
PM (TTM) 1.56%
GM 63.55%
FCFM N/A
ROA(3y)0.96%
ROA(5y)-2.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.5%
ROIC(5y)N/A
ROICexc(3y)6.78%
ROICexc(5y)N/A
ROICexgc(3y)8.36%
ROICexgc(5y)N/A
ROCE(3y)7.5%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.24%
ROICexc growth 3YN/A
ROICexc growth 5Y1.34%
OM growth 3YN/A
OM growth 5Y-5.99%
PM growth 3YN/A
PM growth 5Y-15.78%
GM growth 3Y3.64%
GM growth 5Y0.67%
F-ScoreN/A
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.55
Quick Ratio 0.44
Altman-Z 0.78
F-ScoreN/A
WACC7.02%
ROIC/WACC0.89
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.65%
EPS 3YN/A
EPS 5Y-17.21%
EPS Q2Q%196.55%
EPS Next Y27.01%
EPS Next 2Y28.34%
EPS Next 3Y25.68%
EPS Next 5Y19.51%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y21.96%
Revenue growth 5Y3.44%
Sales Q2Q%4.58%
Revenue Next Year6.47%
Revenue Next 2Y5.63%
Revenue Next 3Y5.16%
Revenue Next 5Y3.74%
EBIT growth 1Y-19.66%
EBIT growth 3YN/A
EBIT growth 5Y-2.75%
EBIT Next Year96.9%
EBIT Next 3Y33.65%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A